Simplex Trading’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.74M Buy
102,200
+88,700
+657% +$2.66M ﹤0.01% 1559
2025
Q4
$416K Sell
13,500
-2,400
-15% -$74.8K ﹤0.01% 3490
2025
Q3
$487K Sell
15,900
-200
-1% -$4.87K ﹤0.01% 3859
2025
Q2
$332K Buy
16,100
+14,500
+906% +$298K ﹤0.01% 3951
2025
Q1
$31K Sell
1,600
-4,300
-73% -$90.2K ﹤0.01% 6216
2024
Q4
$123K Buy
5,900
+5,600
+1,867% +$123K ﹤0.01% 4984
2024
Q3
$7K Hold
300
﹤0.01% 7422
2024
Q2
$7K Sell
300
-1,100
-79% -$31.2K ﹤0.01% 7671
2024
Q1
$41K Sell
1,400
-200
-13% -$5.88K ﹤0.01% 6436
2023
Q4
$50K Sell
1,600
-4,400
-73% -$138K ﹤0.01% 6072
2023
Q3
$211K Buy
6,000
+5,300
+757% +$202K ﹤0.01% 4291
2023
Q2
$26K Sell
700
-12,300
-95% -$490K ﹤0.01% 6495
2023
Q1
$490K Buy
+13,000
New +$500K ﹤0.01% 3287
2022
Q4
Sell
-100
Closed -$3K 9609
2022
Q3
$3K Hold
100
﹤0.01% 9082
2022
Q2
$3K Buy
+100
New +$3.24K ﹤0.01% 9140
2022
Q1
Sell
-600
Closed -$23K 10748
2021
Q4
$23K Sell
600
-1,900
-76% -$79.2K ﹤0.01% 8191
2021
Q3
$103K Hold
2,500
﹤0.01% 6582
2021
Q2
$102K Buy
2,500
+2,474
+9,515% +$95.5K ﹤0.01% 6700
2021
Q1
$85K Buy
+26
New +$978 ﹤0.01% 5958
2020
Q2
Sell
-1
Closed -$2K 7856
2020
Q1
$2K Sell
1
-2
-67% -$45 ﹤0.01% 7183
2019
Q4
$6K Buy
+3
New +$65 ﹤0.01% 6618

Other funds holding GMAB

Simplex Trading's GMAB Position: Q3 2025 in Review

Simplex Trading sold out of Genmab (GMAB) in Q3 2025, closing a stake of 5,630 shares — an estimated $137K sold.

Simplex Trading first reported a position in GMAB in Q1 2021 and held it in 14 quarters. The position peaked at $1.24M in Q1 2025. 252 funds tracked by Wall St. Rank hold GMAB as of Q3 2025.

  • Simplex Trading reported no remaining Genmab position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 5,630 Genmab shares in Q3 2025, an estimated $137K.
  • Simplex Trading first reported a position in Genmab in Q1 2021 and held it in 14 quarters.
  • Simplex Trading's Genmab position peaked at $1.24M in Q1 2025.
  • 252 funds tracked by Wall St. Rank held Genmab as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.